Cargando…
Therapy of newly diagnosed follicular lymphoma
Newly diagnosed follicular lymphoma is relatively common and can be effectively treated with several differing approaches. Although the disease is often considered incurable, it is highly responsive to therapy when indicated. This review discusses the indications for treatment, risk stratification s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518764/ https://www.ncbi.nlm.nih.gov/pubmed/23248775 http://dx.doi.org/10.3389/fonc.2012.00188 |
| _version_ | 1782252578259599360 |
|---|---|
| author | Westin, Jason R. Neelapu, Sattva S. |
| author_facet | Westin, Jason R. Neelapu, Sattva S. |
| author_sort | Westin, Jason R. |
| collection | PubMed |
| description | Newly diagnosed follicular lymphoma is relatively common and can be effectively treated with several differing approaches. Although the disease is often considered incurable, it is highly responsive to therapy when indicated. This review discusses the indications for treatment, risk stratification systems, treatment options with supporting clinical trial data, and expected therapeutic outcomes in newly diagnosed follicular lymphoma. |
| format | Online Article Text |
| id | pubmed-3518764 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35187642012-12-17 Therapy of newly diagnosed follicular lymphoma Westin, Jason R. Neelapu, Sattva S. Front Oncol Oncology Newly diagnosed follicular lymphoma is relatively common and can be effectively treated with several differing approaches. Although the disease is often considered incurable, it is highly responsive to therapy when indicated. This review discusses the indications for treatment, risk stratification systems, treatment options with supporting clinical trial data, and expected therapeutic outcomes in newly diagnosed follicular lymphoma. Frontiers Media S.A. 2012-12-11 /pmc/articles/PMC3518764/ /pubmed/23248775 http://dx.doi.org/10.3389/fonc.2012.00188 Text en Copyright © Westin and Neelapu. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
| spellingShingle | Oncology Westin, Jason R. Neelapu, Sattva S. Therapy of newly diagnosed follicular lymphoma |
| title | Therapy of newly diagnosed follicular lymphoma |
| title_full | Therapy of newly diagnosed follicular lymphoma |
| title_fullStr | Therapy of newly diagnosed follicular lymphoma |
| title_full_unstemmed | Therapy of newly diagnosed follicular lymphoma |
| title_short | Therapy of newly diagnosed follicular lymphoma |
| title_sort | therapy of newly diagnosed follicular lymphoma |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518764/ https://www.ncbi.nlm.nih.gov/pubmed/23248775 http://dx.doi.org/10.3389/fonc.2012.00188 |
| work_keys_str_mv | AT westinjasonr therapyofnewlydiagnosedfollicularlymphoma AT neelapusattvas therapyofnewlydiagnosedfollicularlymphoma |